Nexalin Technology (NXL) EBT (2021 - 2026)

Nexalin Technology's EBT history runs 6 years deep, the most recent figure standing at -$2.1 million for Q1 2026.

• In Q1 2026, EBT fell 5.51% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at -$8.3 million (up 2.59% YoY), while the FY2025 annual figure was -$8.2 million, down 8.0% from the prior year.
• EBT was -$2.1 million for Q1 2026 at Nexalin Technology, up from -$2.4 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$303646.0 in Q3 2022 to a low of -$2.8 million in Q4 2024.
• Historically, EBT has averaged -$1.4 million across 5 years, with a median of -$1.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: EBT jumped 83.34% in 2022, then slumped 656.54% in 2023.
• A 5-year view of EBT shows it stood at -$733113.0 in 2022, then retreated by 6.49% to -$780669.0 in 2023, then sank by 262.95% to -$2.8 million in 2024, then rose by 16.13% to -$2.4 million in 2025, then climbed by 11.77% to -$2.1 million in 2026.
• The last three EBT figures came in at -$2.1 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.